Envestnet Asset Management Inc Global Blood Therapeutics, Inc. Transaction History

Envestnet Asset Management Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 07, 2021	SELL	$25.48 - $37.34 $207,025 - $303,387	-8,125 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$32.46 - $43.42 $45,606 - $61,005	-1,405 Reduced 14.74%	8,125 $285,000
Q1 2021 May 04, 2021	SELL	$38.94 - $50.85 $51,945 - $67,833	-1,334 Reduced 12.28%	9,530 $388,000
Q4 2020 Feb 02, 2021	BUY	$37.65 - $63.77 $409,029 - $692,797	10,864 New	10,864 $471,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Envestnet Asset Management Inc with notifications on news.